By a number of traditional measures, John F. Kerry, a decorated veteran and long-serving senator, is qualified to be secretary of defense. But recent reports that President Obama is considering the Bay State’s senior senator to run the Pentagon during his second term puzzled many longtime defense watchers and political analysts who assumed Kerry, chairman of the Foreign Relations Committee, was on a very short list to replace Secretary of State Hillary Clinton.
The confetti has barely been swept off the floor, but Masssachusetts could be headed for yet another Senate race. Just days after the end of a grueling campaign, potential candidates are quietly scrambling to position themselves to run for Senator John F. Kerry’s seat if President Obama appoints Kerry to be his next secretary of state, or secretary of defense. A Senate vacancy would probably create a comeback scenario for Senator Scott Brown, the Republican who lost the seat to Democrat Elizabeth Warren in last week’s election.
As Elizabeth Warren walked through the marble corridors of the United States Capitol on Tuesday, she tried to keep a low profile. Walking arm in arm with Senator-elect Tammy Baldwin of Wisconsin, they passed paintings of historic politicians, busts of former vice presidents, and the doors to the Senate floor they will enter once sworn in. A small gaggle of reporters awaited one of the rising stars in Washington, and Warren knew it. She leaned into Baldwin and was overheard saying, “Pretend you’re talking to me.” She answered no questions, and strolled into a luncheon as reporters from the biggest news organizations in the country scolded themselves for not getting more information.
State pharmacy regulators on at least two occasions in the past decade displayed indifference in their oversight of a troubled Framingham specialty pharmacy that has now been blamed for a national fungal meningitis outbreak, according to documents obtained by the Globe Tuesday. While state and federal regulators were investigating New England Compounding Center for problems with sterile drug preparation, the company’s lead pharmacist was chosen to serve on a state pharmacy board task force to write new rules for compounding pharmacies.